###begin article-title 0
Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Metalloproteinase inhibitors can protect mice against experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis (MS). Matrix metalloproteinase-9 (MMP-9) has been implicated, but it is not clear if other MMPs are also involved, including matrilysin/MMP-7 - an enzyme capable of cleaving proteins that are essential for blood brain barrier integrity and immune suppression.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 41 44 41 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 187 190 187 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 607 609 607 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 616 618 616 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 671 675 671 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 675 679 675 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 804 808 804 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 808 812 808 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 874 878 874 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 878 882 878 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 990 999 990 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 190 194 <span type="species:ncbi:10090">mice</span>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 533 539 <span type="species:ncbi:4081">tomato</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
###xml 812 816 <span type="species:ncbi:10090">mice</span>
Here we report that MMP-7-deficient (mmp7-/-) mice on the C57Bl/6 background are resistant to EAE induced by myelin oligodendrocyte glycoprotein (MOG). Brain sections from MOG-primed mmp7-/-mice did not show signs of immune cell infiltration of the CNS, but MOG-primed wild-type mice showed extensive vascular cuffing and mononuclear cell infiltration 15 days after vaccination. At the peak of EAE wild-type mice had MMP-7 immuno-reactive cells in vascular cuffs that also expressed the macrophage markers Iba-1 and Gr-1, as well as tomato lectin. MOG-specific proliferation of splenocytes, lymphocytes, CD4+ and CD8+ cells were reduced in cells isolated from MOG-primed mmp7-/- mice, compared with MOG-primed wild-type mice. However, the adoptive transfer of splenocytes and lymphocytes from MOG-primed mmp7-/- mice induced EAE in naive wild-type recipients, but not naive mmp7-/- recipients. Finally, we found that recombinant MMP-7 increased permeability between endothelial cells in an in vitro blood-brain barrier model.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
Our findings suggest that MMP-7 may facilitate immune cell access or re-stimulation in perivascular areas, which are critical events in EAE and multiple sclerosis, and provide a new therapeutic target to treat this disorder.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 640 641 640 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 795 796 795 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 797 798 797 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 839 840 839 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1338 1339 1338 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1340 1342 1340 1342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1495 1497 1495 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1255 1260 <span type="species:ncbi:9606">human</span>
###xml 1264 1272 <span type="species:ncbi:9606">patients</span>
Multiple sclerosis (MS) is an autoimmune disorder marked by the infiltration of pathogenic T cells into the central nervous system (CNS) that cause inflammation and oligodendrocyte cell death. In an animal model of MS, called experimental autoimmune encephalomyelitis (EAE), vaccination with CNS-myelin-derived peptides triggers the expansion of oligodendrocyte-specific T cells and a pathological profile that includes CNS inflammation, demyelination, and paralysis. Transmigration of pathogenic T cells across the blood-brain barrier (BBB) is facilitated by the expression of cell adhesion molecules and proteinases that degrade the ECM [1]. The discovery that EAE can be prevented by broad spectrum metalloproteinase inhibitors implicated this large family of enzymes in disease progression [1-5] and has led to recent clinical trials [6]. Matrix metalloproteinases (MMPs) are extracellular enzymes that can cleave ECM and non-matrix proteins, including laminin, collagen, cytokines, other proteinases, and the ectodomains of several membrane proteins. MMPs are usually secreted as pro-enzymes that can be cleavage-activated by plasminogen activators, trypsin, other MMPs, and oxidation. Elevated levels of MMP-2, MMP-7 and MMP-9 have been reported in human MS patients, and in brain and spinal cord extracts from EAE-induced rodents [7-17]. In a delayed-type hypersensitivity model for MS, MMP-7 was found to be the most up-regulated MMP, compared with MMP-2,3,8,9,10,11,12,13,14,15 and 16 [11].
###end p 9
###begin p 10
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 579 581 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 821 823 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 915 917 915 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 936 938 933 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 954 956 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 971 973 968 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 974 976 971 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1023 1025 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1150 1152 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 400 408 <span type="species:ncbi:9606">patients</span>
###xml 468 472 <span type="species:ncbi:10090">mice</span>
Within tissues, MMPs usually reside in extracellular spaces as inactive proforms, and factors that activate even a small proportion of those MMPs have significant biological effects. Therefore, determining which factors contribute to MMP activity in MS will be critical to understanding the role(s) these enzymes play in this disorder. Cerebrospinal fluid levels of MMP-9 activity are elevated in MS patients and in rodent models of EAE [18], and young MMP-9 knockout mice (4 weeks) are resistant to EAE [19]. MMP-2 plays a critical role in angiogenesis and vascular remodeling [20]. Although MMP-2 expression does not increase in MS or EAE, MMP-2 activation may contribute to localized permeabilization of the cerebrovasculature. MMP-2 and MMP-9 are structurally similar gelatinases that can each be activated by MMP-7 [21]. MMP-7 can also cleave many EAE-relevant substrates, including laminin, type IV collagen [22], beta4-integrin [23], VE-cadherin [24], E-cadherin [25-27] and the immune suppressor Fas ligand (FasL) [28]. Further, MMP-7 has been reported as necessary for the trans-epithelial efflux of immune cells in bleomycin-treated lungs [29], which is similar to the extravasation that immune cells must make in EAE and MS.
###end p 10
###begin p 11
###xml 919 921 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 934 936 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1064 1066 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1125 1127 1125 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 503 511 <span type="species:ncbi:9606">patients</span>
Myelin-specific T cells can be detected in the blood of MS patients and EAE-induced mice even during periods of remission, when they no longer persist in the CNS. Tight junctions between microvascular endothelial cells within the brain prevent the direct entry of macromolecules and blood-borne cells, forming the BBB. Compromise of BBB integrity facilitates immune cell access to the CNS and is essential for MS and EAE. For example, MRI detection of gadolinium accumulation in the brain lesions of MS patients is an indicator of compromised BBB integrity and a reliable predictor of pending disease activity. Factors that affect the cell-to-cell contacts of cerebrovascular endothelial cells, or their viability, can reduce BBB integrity and increase immune cell access to the CNS. VE-cadherin is an important component of tight junctions between endothelial cells and is also a substrate for cleavage by both MMP-7 [24] and MMP-9 [30]. The two layers or ECM that surround the cerebrovasculature contain laminin and type IV collagen, which are cleaved by MMP-7 [22], as well as collagens and elastins are cleaved by MMP-9 [31].
###end p 11
###begin p 12
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 908 910 908 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 911 913 911 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1024 1026 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
In addition to the BBB, immune cells actions are restricted within the CNS action by the expression of cell death ligands CD95L/Fas ligand/FasL and TRAIL that can trigger apoptosis in activated T cells and myeloid cells. FasL is a potent inducer of apoptosis in activated T cells [32] and its expression is elevated in response to injuries that compromise BBB integrity [15,33-35]. Facial nerve damage locally increases FasL expression and T cell apoptosis around the facial nucleus in EAE-induced mice [36]. The availability of FasL is closely regulated at the transcriptional and post-translational levels, which includes proteolytic cleavage of its receptor binding region by MMP-3 [37] and MMP-7 [28,38]. While membrane-bound FasL has potent pro-apoptotic activity for activated T cells, cleaved or soluble FasL (sFasL) shows differential effects, depending on the disease model and specific cell types [39,40]. Moreover, sFasL has a chemotaxic effect on mononuclear cells, which can be blocked by anti-FasL antibodies [41].
###end p 12
###begin p 13
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 107 109 107 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt</italic>
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 119 123 119 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 261 266 261 266 <sub xmlns:xlink="http://www.w3.org/1999/xlink">35&#8211;55</sub>
###xml 435 436 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 445 447 445 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 582 585 582 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 589 593 589 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 593 597 593 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 748 757 748 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 597 601 <span type="species:ncbi:10090">mice</span>
Here, we used MMP-7-deficient (mmp7-/-) mice to investigate the role of this proteinase in EAE. Wild-type (wt) and mmp7-/- mice were compared for clinical and immunological responses to an encephalitogenic fragment of myelin oligodendrocyte protein peptide (MOG35-55). Localization of MMP-7 expression in the CNS was examined during EAE in MOG-primed mice at the peak of EAE. MOG-specific proliferation of splenocytes, lymphocytes, CD4+, and CD8+ T cells were compared in both strains of mice. We also used adoptive transfer to assess the encephalitogenic potential of T cells from wt and mmp7-/- mice to induce EAE in recipients of both strains. Finally, we tested the effects of active MMP-7 on endothelial cell connectivity using an established in vitro model of the BBB.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 8 12 <span type="species:ncbi:10090">Mice</span>
mmp7-/- Mice Are Resistant to EAE
###end title 15
###begin p 16
###xml 80 83 80 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 91 95 91 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 145 150 145 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink">35&#8211;55</sub>
###xml 198 201 198 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 453 457 453 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 457 461 457 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 510 513 510 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 517 521 517 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 521 524 521 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
To determine if MMP-7 plays a critical role in EAE we compared the responses of wt and mmp7-/- mice, congenic with the C57Bl/6 background, to MOG35-55. Clinical evidence of EAE was observed in 9/12 wt mice (75%), with scores up to 2.5 and an average peak near 1.6 (Figure 1a). Clinical scores showed paralysis beginning 12-14 days after MOG injection, which was consistent with previous reports of mice with this genetic background [42,43]. None of the mmp7-/- mice showed any paralysis (0/9, 0%). Age-matched wt and mmp7-/-mice were injected simultaneously in 3 separate experiments, with similar results.
###end p 16
###begin p 17
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 18 22 18 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 75 80 75 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink">35&#8211;55</sub>
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Wild-type and <italic>mmp7</italic><sup>-/- </sup>mice show respond differently to vaccination with MOG<sub>35&#8211;55</sub></bold>
###xml 116 119 116 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 136 140 136 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 170 175 170 175 <sub xmlns:xlink="http://www.w3.org/1999/xlink">35&#8211;55</sub>
###xml 319 323 319 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 323 327 323 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 628 632 628 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 632 636 632 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 710 713 710 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 797 801 797 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 801 805 801 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 853 856 853 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 1022 1026 1022 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 1026 1030 1026 1030 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 495 500 <span type="species:ncbi:10090">mouse</span>
###xml 636 641 <span type="species:ncbi:10090">mouse</span>
###xml 713 718 <span type="species:ncbi:10090">mouse</span>
###xml 805 809 <span type="species:ncbi:10090">mice</span>
###xml 856 861 <span type="species:ncbi:10090">mouse</span>
###xml 1030 1034 <span type="species:ncbi:10090">mice</span>
Wild-type and mmp7-/- mice show respond differently to vaccination with MOG35-55. (a) Mean clinical EAE scores from wt (n = 12) and mmp7-/- (n = 9) mice injected with MOG35-55: graphed values are from two separate experiments. The first cadre of mice were sacrificed at day 15 for histological analysis (blue circles). mmp7-/- mice did not show clinical signs of EAE. Error bars represent SEM (*p < 0.05; **p < 0.005). (b) Haematoxylin and eosin staining of a brain section from a MOG-primed WT mouse shows perivascular cuffing of mononuclear cells. (c) Haematoxylin and eosin staining of a comparable section from a MOG-primed mmp7-/- mouse shows no vascular cuffing. (d) Spinal cord sections from MOG-primed wt mouse showing cuffing (e) that was not seen in spinal cord sections from MOG-primed mmp7-/- mice. (f) Spinal cord section from a MOG-primed wt mouse showing immune cells infiltration at the lateral edge and deeper into the parenchyma, (g) which was not seen in any spinal cord sections from similarly treated mmp7-/- mice. Scale bars = 100 mum.
###end p 17
###begin p 18
###xml 55 58 55 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 178 183 178 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b, d</xref>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 288 292 288 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 305 310 305 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c, e</xref>
###xml 313 316 313 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1f</xref>
###xml 503 507 503 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 507 511 507 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1g</xref>
###xml 558 562 558 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 562 566 562 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 619 622 619 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 316 320 <span type="species:ncbi:10090">mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
###xml 566 570 <span type="species:ncbi:10090">mice</span>
###xml 622 626 <span type="species:ncbi:10090">mice</span>
Haematoxylin and eosin staining of brain sections from wt mice isolated 15 days after MOG injection, near the peak of EAE, showed extensive mononuclear cell infiltration (Figure 1b, d). Perivascular cuffing, a classic feature of encephalitis, was not seen in the brains of MOG-primed mmp7-/- mice (Figure 1c, e). wt mice also showed patches of demyelination adjacent to perivascular cuffs that were infiltrated by mononuclear cells and contained pycnotic nuclei (Figure 1f), all of which were absent in mmp7-/- mice (Figure 1g). These findings indicate that mmp7-/- mice are resistant to a stimulus that induces EAE in wt mice.
###end p 18
###begin title 19
Myeloid Cells Are the Primary Expressers of MMP-7 during EAE
###end title 19
###begin p 20
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 372 377 372 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a, b</xref>
###xml 399 400 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2c&#8211;f</xref>
###xml 773 774 773 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 958 960 958 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1073 1075 1073 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 729 735 <span type="species:ncbi:4081">tomato</span>
MMP-7 expression in wt mice was localized by immunostaining sections from brains that were isolated during EAE, 15 days after vaccination. Previous reports have described elevated MMP-7 levels in brain and spinal cord during delayed type hypersensitivity and EAE, up to 500-fold over controls [11,13]. We observed strong MMP-7 immunostaining in perivascular cuffs (Figure 2a, b; see Additional file 1), in cells that co-stained for the monocyte marker Iba-1 (Figure 2c-f). Most MMP-7/Iba-1 immunopositive cells were in close proximity to vascular structures, but several cells were within the parenchyma and notably enlarged, possibly due to active phagocytosis. Further immunostaining revealed that MMP-7 also co-localized with tomato lectin and Gr-1 (see Additional file 2), common though less specific markers for myeloid cells. Although MMP-7 is an extracellular proteinase, it binds strongly to heparan sulphate on the surface of MMP-7-producing cells [44]. Interestingly, heparan sulfate proteoglycans have been reported to mediate monocyte migration across the BBB [45].
###end p 20
###begin p 21
###xml 77 80 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 0 95 0 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Confocal and epifluorescence images of MMP-7 immuno-reactivity in the CNS of <italic>wt </italic>mice during EAE</bold>
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 286 289 286 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 133 138 <span type="species:ncbi:10090">mouse</span>
###xml 289 294 <span type="species:ncbi:10090">mouse</span>
Confocal and epifluorescence images of MMP-7 immuno-reactivity in the CNS of wt mice during EAE. Brain sections were taken from a wt mouse 15 days after vaccination with MOG, when the EAE clinical score was 1. (a) Fluorescence microscope image of MMP-7 immunostaining in the brain of a wt mouse, scale bar = 50 mum. (b) Confocal microscope image of MMP-7 immunostaining in another region, scale bar = 10 mum. (c) MMP-7 immunostaining (red) shows strong labelling of many cells in the vascular cuff, (d) which co-localizes with Iba-1 immunoreactivity (green). (e) DAPI staining reveals the nuclear morphology of all cells in the cuff and surrounding parenchyma. (f) A merged image of c-e shows co-localization of Iba-1 and MMP-7 in the same cells. Arrows indicate double-stained cells in the parenchyma that have a spread-distended appearance. The lumen of the blood vessel is indicated with "v", scale bar = 100 mum.
###end p 21
###begin p 22
###xml 545 549 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a&#8211;d</xref>
###xml 836 838 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 839 841 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 334 338 <span type="species:ncbi:10090">Mice</span>
Endothelial cells in the cerebrovasculature are surrounded by astrocyte end-feet processes, which regulate BBB integrity. Reactive astrocytes produce a variety of factors in response to injury and infection, so we examined whether astrocytes expressed MMP-7 during EAE by co-immunostaining for glial fibrillary acidic protein (GFAP). Mice with high EAE clinical scores showed robust MMP-7 immunoreactivity around inflamed vascular structures, but within the parenchyma MMP-7 immunoreactivity did not co-localize with GFAP-positive cells (Figure 3a-d). Although astrocyte end-feet were adjacent to cells with strong MMP-7 staining, GFAP-positive cells did not appear to express the enzyme. These findings indicate that macrophages and not astrocytes are the primary producers of MMP-7 during EAE, which is consistent with other reports [46-48].
###end p 22
###begin p 23
###xml 98 101 98 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 0 116 0 116 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MMP-7 immunoreactivity does not co-localize with the astrocyte marker GFAP, or CD4, in the CNS of <italic>wt </italic>mice during EAE</bold>
###xml 151 154 151 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 806 808 805 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 154 159 <span type="species:ncbi:10090">mouse</span>
MMP-7 immunoreactivity does not co-localize with the astrocyte marker GFAP, or CD4, in the CNS of wt mice during EAE. Brain sections were taken from a wt mouse 15 days after vaccination with MOG, when the EAE clinical score was 1. (a) MMP-7 (green) and (b) GFAP (red) immunopositive cells. (c) DAPI staining of nuclei. (d) Merged image showing that GFAP and MMP-7 do not co-localize to the same cells although there are interactions between these two immunopositive populations. Scale bar = 50 mum. (e) CD4 immunostaining in the choroid plexus. Intensity of the red signal was increased to show choroid plexus structures, from auto-fluorescence. (f) MMP-7 immunostaining (green) shows several immunopositive cells between endothelial sheets, on the vascular side. (g) Merged image of e and f shows that CD4+ and strong MMP-7 immunostaining do not co-localize. Arrow indicates continuity between an MMP-7 immunopositive cell and the lateral ventricle.
###end p 23
###begin p 24
###xml 536 538 536 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 629 633 629 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3e&#8211;g</xref>
###xml 981 983 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3c</xref>
The choroid plexus consists of highly vascularized structures that produce cerebrospinal fluid (CSF) within brain ventricles. Although choroid plexus has highly fenestrated capillaries, blood components are kept separate from cerebrospinal fluid by tight junctions between specialized ependymal cells in the outer layer, constituting the blood-CSF barrier (BCB). Between fenestrated capillaries and ependymal cell layers is a basal lamina composed largely of collagen in which we observed strong immunoreactivity for MMP-7. Notably, CD4+ T cells were observed between these layers but did not show MMP-7 immunoreactivity (Figure 3e-g). Accumulation of MMP-7 within the choroid plexus may degrade components of the basal lamina and connective tissue, or disrupt cadherin-mediated contacts. Indeed, confocal microscopy revealed patches of MMP-7 that appeared to breach the ependymal layer of the choroid plexus and become continuous with the CSF-containing lateral ventricle (Figure 3c). Significantly, such breaches in the BCB would permit the passage of immunoglobulins and serum proteins into the CSF, an important diagnostic indicator of MS.
###end p 24
###begin title 25
MMP-7-Deficiency Diminishes MOG-specific T cell Responses
###end title 25
###begin p 26
###xml 125 128 125 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 136 140 136 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 146 154 146 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 267 268 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 317 320 317 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 324 328 324 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 328 332 328 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 351 352 351 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 469 470 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 511 515 510 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 515 519 514 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 545 548 544 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 591 595 590 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 595 599 594 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 654 662 653 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 678 680 677 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt</italic>
###xml 819 823 818 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 823 827 822 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 894 902 893 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
###xml 827 831 <span type="species:ncbi:10090">mice</span>
To determine whether a lack of MMP-7 prevents MOG-specific immune responses, we assayed representative cell populations from wt and mmp7-/- mice, in vitro. Splenocytes and lymphocytes were isolated from mice 15 days after MOG-injection and then cultured with MOG and 3H-thymidine. After 4 days, splenocytes from both wt and mmp7-/- mice showed higher 3H-thymidine incorporation in response to MOG (10, 20, or 30 mug/ml) when compared with controls (see Additional file 3). However, MOG-induced proliferation of mmp7-/- splenocytes was less than wt cells. Primary lymphocytes from MOG-primed mmp7-/- mice also showed less proliferation in response to MOG in vitro, compared with wt. Higher density lymphocyte cultures showed similar results (not shown). These findings demonstrated that splenocytes and lymphocytes from mmp7-/- mice have lower antigen-specific proliferation in response to MOG, in vitro.
###end p 26
###begin p 27
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 139 141 139 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 148 150 148 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 215 223 215 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 236 238 236 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 251 254 251 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
###xml 631 633 631 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4c</xref>
###xml 649 651 649 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 684 688 684 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 688 692 688 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 781 785 781 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4d&#8211;f</xref>
###xml 830 832 830 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 856 860 856 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 860 864 860 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 894 896 894 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt</italic>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
###xml 864 868 <span type="species:ncbi:10090">mice</span>
The proliferation of T cells can only be inferred from 3H-thymidine incorporation studies, so we investigated MOG-specific responses of CD4+ and CD8+ T cells using CFSE pre-labelling and FACS analysis. After 4 days in vitro, control CD4+ T cells from wt mice proliferated up to 4 generations, with further divisions making a negligible component (Figure 4a). Further proliferation was induced by IL-2 with a small, but measurable proportion of cells dividing up to 9 generations (Figure 4b). MOG induced a higher proportion of cells beyond 4 generations than did IL-2, constituting nearly 9.5% of the original cells that became CD4+ (Figure 4c). CD4+ T cells isolated from MOG-primed mmp7-/- mice showed similar responses to IL-2, but less proliferation in response to MOG (Figure 4d-f). Although MOG-specific proliferation of CD4+ T cells from MOG-primed mmp7-/- mice was less with MOG-primed wt, MOG-specific proliferation was present.
###end p 27
###begin p 28
###xml 26 28 26 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 99 102 99 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 110 114 110 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 130 0 130 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Generation analysis of CD4<sup>+ </sup>cells in mixed splenocyte/lymphocyte cultures isolated from MOG-primed <italic>wt </italic>and <italic>mmp7</italic><sup>-/- </sup>mice, using CFSE</bold>
###xml 142 144 142 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 155 158 155 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 331 334 330 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 438 440 437 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 477 481 476 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 481 485 480 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 516 519 515 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 630 633 629 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
Generation analysis of CD4+ cells in mixed splenocyte/lymphocyte cultures isolated from MOG-primed wt and mmp7-/- mice, using CFSE. (a, b) CD4+ cells from wt mice had a small response to IL-2, (c) and a more robust response to MOG (10 mug/ml). For a-c, percentages indicate the proportion of initial cells that divided beyond the 4th generation, which was the farthest significant generation for media-only controls shown in a. (d, e) CD4+ proliferation in response to IL-2 in mmp7-/- mice was comparable to that in wt cells. (f) MOG-induced proliferation was comparable to that from IL-2 stimulation - less than the responses of wt cells to MOG.
###end p 28
###begin p 29
###xml 18 20 18 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 64 66 64 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a</xref>
###xml 277 280 277 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5b</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5c</xref>
###xml 360 362 360 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 384 388 384 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 388 392 388 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5d</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5e</xref>
###xml 585 588 585 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 596 598 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5f</xref>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
In addition to CD4+ T cells, the transfer of myelin-specific CD8+ T cells can also cause severe EAE [34]. CFSE analysis showed that CD8-expressing T cells did not proliferate past 4 generations in control cultures (Figure 5a). However, significant proliferation of up to the 10th generation was observed in response to IL-2 (Figure 5b) and MOG (Figure 5c). CD8+ T cells isolated from mmp7-/- mice also showed minimal proliferation in control media (Figure 5d) and substantial proliferation in response to IL-2 (Figure 5e), but again MOG-induced proliferation was reduced compared with wt (Figure 5f).
###end p 29
###begin p 30
###xml 26 28 26 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 59 62 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 70 74 70 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Generation analysis of CD8<sup>+ </sup>cells isolated from MOG-primed <italic>wt </italic>and <italic>mmp7</italic><sup>-/- </sup>mice, using CFSE</bold>
###xml 166 168 166 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 177 180 177 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 234 238 234 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 280 282 280 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt</italic>
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 296 300 296 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
Generation analysis of CD8+ cells isolated from MOG-primed wt and mmp7-/- mice, using CFSE. (a, b) The proportion of IL-2-responsive progenitors that gave rise to CD8+ cells in wt mice was comparable to that observed with (d, e) MMP-7-/- mice. (c, f) MOG-responses were robust in wt, but not mmp7-/- progenitors. Percentages indicate the proportion of progenitors that surpassed the farthest generation of media-only controls (a, d).
###end p 30
###begin title 31
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 71 75 71 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 36 40 <span type="species:ncbi:10090">Mice</span>
Transfer of T cells from MOG-primed Mice Induced EAE in wt but not mmp7-/- Recipients
###end title 31
###begin p 32
###xml 30 32 30 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 39 41 39 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 81 85 81 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 156 160 156 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 296 300 296 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 300 304 300 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 335 343 335 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 400 404 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 404 408 404 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 412 415 412 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 445 448 445 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 558 559 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 670 673 670 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 710 714 710 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 714 718 714 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 828 832 828 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 832 836 832 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 900 903 900 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 1125 1129 1125 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 1129 1133 1129 1133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1224 1228 1224 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 1228 1232 1228 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1284 1288 1284 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 1288 1292 1288 1292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1295 1298 1295 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 836 840 <span type="species:ncbi:10090">mice</span>
###xml 903 907 <span type="species:ncbi:10090">mice</span>
###xml 1044 1048 <span type="species:ncbi:10090">mice</span>
###xml 1080 1084 <span type="species:ncbi:10090">mice</span>
###xml 1232 1236 <span type="species:ncbi:10090">mice</span>
###xml 1298 1302 <span type="species:ncbi:10090">mice</span>
We found that MOG-specific CD4+ and CD8+ T cell proliferation was reduced in mmp7-/- mice, but still present, so we tested if MOG-specific T cells from mmp7-/- mice were encephalitogenic using adoptive transfer. To examine this possibility we isolated splenocytes and lymphocytes from MOG-primed mmp7-/- donors, re-stimulated with MOG in vitro, and then adoptively transferred those cells into naive mmp7-/- and wt recipients. Within 4 days all wt recipients (7/7) showed signs of paralysis that persisted for the entire 25 day post-injection period (Figure 6). Although EAE scores were low, difficulties with balance and gripping a tilted cage top were apparent in all wt recipients. In contrast, none of the mmp7-/- recipients (0/6) showed any signs of EAE during the 25 day post-transfer period. These findings indicate that mmp7-/- mice produce encephalitogenic T cells that can cause disease in wt mice, even though they have reduced T cell responses to MOG. In a reciprocal study, we found that splenocytes/lymphocytes from MOG-primed wt mice could also cause disease in wt mice (3/3), with clinical scores of 1-2, but mmp7-/- recipients were resistant to the encephalitogenic effects of those cells (0/3). Therefore, mmp7-/- mice are resistant to encephalitogenic T cells from mmp7-/- or wt mice.
###end p 32
###begin p 33
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 84 87 84 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 0 97 0 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>mmp7</italic><sup>-/- </sup>mice generate encephalitogenic T cells that produce EAE when transferred to <italic>wt </italic>recipients</bold>
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 149 153 149 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 193 195 193 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 249 253 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 253 257 253 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
mmp7-/- mice generate encephalitogenic T cells that produce EAE when transferred to wt recipients. Graph indicating EAE scores in wt (n = 7) and mmp7-/- (n = 6) recipients that received 20 x 106 re-stimulated splenocytes/lymphocytes from MOG-primed mmp7-/- donors. Errors bars represent SEM (**p < 0.01; **p < 0.005).
###end p 33
###begin title 34
MMP-7 Affects the Permeability of Brain Endothelial Cell Barriers
###end title 34
###begin p 35
###xml 123 132 123 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1056 1057 1056 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1249 1250 1249 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 257 260 <span type="species:ncbi:10116">rat</span>
###xml 340 343 <span type="species:ncbi:10116">rat</span>
To test whether MMP-7 affects tight junctions between cerebrovascular endothelial cells of the BBB, we used an established in vitro model consisting of porous hollow fibres and perfusion to replicate the pressure dynamics of brain capillaries [49]. Primary rat brain micro-vascular endothelial cells were grown inside the tubes and primary rat-brain astrocytes outside. Constant media flow through the lumen replicates the shear dynamics for vascular endothelial cells that line the tubes. After several days tight junctions connect endothelial cells lining the lumen to the extent that a trans-endothelial electrical resistance (TEER) can be measured. These junctions between endothelial cells depend on VE-cadherin, a substrate for MMP-7 [24]. We tested whether recombinant MMP-7 could alter permeability across these layers of brain endothelial cells by measuring the TEER. MMP-7 added to the brain-side (ECS) compartment did not decrease TEER and even slightly increased TEER by an as yet undetermined mechanism that may work through astroglia (Figure 7). However, MMP-7 affected the vascular endothelial cells when placed on lumenal side (Lumen) and caused a near-term 15-20% drop in TEER, with a subsequent drop of 40-45% after 4 days (Figure 7). This loss of electrical resistance is consistent with increased permeability of the endothelial cell layer lining the lumen of the micro-capillaries. Therefore, high local concentrations of MMP-7, as found on the surface of macrophages, can reduce the integrity of endothelial cell-to-cell contacts and may facilitate the transmigration of immune cells across the BBB.
###end p 35
###begin p 36
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of MMP-7 on BBB permeability as measured in vitro by TEER</bold>
###xml 235 237 235 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
Effects of MMP-7 on BBB permeability as measured in vitro by TEER. Electrical potential between the extracellular side (ECS) and the luminal side as measured by TEER. After establishing the system, the TEER is typically ~650-700 Ohm/cm2 (black). The addition of MMP-7 to the luminal side resulted in a 15-20% drop in TEER during a 2 h halt in flow (green). This drop in TEER continued over the next 4 days, eventually resulting in a 40% reduction in TEER. The addition of recombinant MMP-7 to the ECS (red) side did not result in a near or longer term decrease in TEER, and slightly increase TEER over the course of the experiment. These two graphs were made from different apparatus, run simultaneously.
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 222 226 222 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 347 351 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 351 355 351 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 425 428 425 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 866 875 866 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 103 111 <span type="species:ncbi:9606">patients</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
High MMP-7 activity has been reported in demyelinating MS lesions and in the cerebrospinal fluid of MS patients [7-10,15], yet the role of this extracellular proteinase in MS is still unclear. Here, we have shown that mmp7-/- mice are resistant to MOG-induced EAE. Diminished T cell responses to MOG make it less likely that EAE will develop, but mmp7-/- mice still produce encephalitogenic T cells that can cause disease in wt mice. Immuno-localization of MMP-7 in areas adjacent to vascular structures suggests that it may facilitate immune access at the BBB. A common diagnostic feature of MS is MRI-detectable breaches of the BBB and spokes of demyelination that project outwardly from a cerebrovascular core (Dawson's fingers). Localization of MMP-7 to breaches of the BBB suggests that it may act directly on BBB integrity. We tested this possibility using an in vitro BBB model and found that the direct exposure of brain endothelial cells to recombinant MMP-7 increased the permeability between those cells. In contrast, MMP-7 did not increase permeability on the brain side of the BBB, but it may have other effects.
###end p 38
###begin p 39
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1053 1055 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 241 245 <span type="species:ncbi:10090">Mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 1009 1013 <span type="species:ncbi:10090">mice</span>
Inside the BBB, MMP-7 may contribute to EAE by activating MMP-2 and MMP-9 (proform), or by reducing immune privilege by cleaving FasL [50]. As a potent inducer of apoptosis in activated T cells, FasL is crucial to the recovery phase of EAE. Mice with defective FasL undergo more severe and prolonged EAE, compared with WT mice [51]. Indeed, CNS injury models have shown that a localized increase of FasL expression within the CNS is a consistent response to breaches of the BBB [33,34]. The potent activity of FasL can be attenuated by shedding the Fas-binding domain by MMP-7 [28,38,39]. Macrophages that infiltrate the CNS and produce high local concentrations of MMP-7 may cause localized shedding of FasL and create discrete pockets of lowered immune privilege within the CNS. This process could prolong the survival of activated T cells that would otherwise die by activation induced cell death or FasL-induced apoptosis. Interestingly, granulocyte macrophage colony stimulating factor (GM-CSF) knockout mice are also resistant to MOG-induced EAE [52]; however, their resistance is attributed to attenuated MOG-specific T cell responses, perhaps due to fewer antigen-presenting cells. Variables that affect macrophage availability might be expected to have a direct impact on MMP-7 production near cerebrovascular structures and also affect EAE susceptibility.
###end p 39
###begin p 40
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
Within the brain MMP-7 may also contribute to memory, motor and cognitive problems that often accompany MS episodes. Recent studies have shown that MMP-7 and MMP-9 can disrupt mature dendritic spines, causing them to assume immature morphologies, which greatly reduces the synaptic strength of excitatory synapses and can impact memory and behaviour [53,54]. Furthermore, EphB receptors are critically important for the formation and maintenance of mature dendritic spines, and MMP-9 has recently been shown to cleave EphB [55]. Infiltrating macrophages in perivascular cuffs or near demyelinating lesions might produce enough MMP-7 to activate extracellular pools of MMP-9 (proform) and disrupt synapse stability in nearby areas - even without demyelination or overt pathology [56].
###end p 40
###begin p 41
###xml 147 149 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 150 152 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 295 297 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 298 300 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 905 907 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 257 265 <span type="species:ncbi:9606">patients</span>
Several cytokines, including TNF-alpha, have been shown to increase MMP-7 expression and have been repeatedly linked with EAE and MS inflammation [57,58]. IFN-beta is a promising treatment for MS and has been shown to repress MMP-7 and MMP-9 expression for patients with relapsing-remitting MS [18,51]. Our findings suggest that MMP-7 plays a role in the extravasation of immune cells during EAE. MMP-7 expression adjacent to the cerebrovasculature and ependymal cells of the choroid plexus suggests that metalloproteinase inhibitors could prevent EAE by blocking MMP-7 activity at these sites. Interestingly, hydroxamate-based metalloproteinase inhibitors can prevent EAE, but may not be able to cross an intact BBB, so their ability to prevent EAE would depend on actions after the BBB has been compromised unless they work by inhibiting MMPs outside of the BBB, such as MMP-7 on circulating monocytes [29].
###end p 41
###begin title 42
Conclusion
###end title 42
###begin p 43
###xml 279 281 279 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 287 289 287 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 193 198 <span type="species:ncbi:10090">mouse</span>
This study demonstrates that MMP-7 plays a critical role in MOG-induced EAE in C57Bl/6 mice, although it is possible that stronger encephalitogenic stimuli (e.g. myelin basic protein) in other mouse strains may respond differently to MMP-7 deficiency. The reduced response of CD4+ or CD8+ T cells to EAE, did not preclude the production of encephalitogenic T cells, and may reflect an important role for MMP-7 in the antigen-presentation or the specialized microenvironment of lymphoid organs. Immuno-localization of MMP-7 to myeloid cells and cerebrovascular structures, along with its ability to increase the permeability between endothelial cells, implicates this enzyme in compromising BBB and/or BCB integrity, and suggests that MMP-7 may have additional effects in the brain parenchyma that extend beyond lymphocyte infiltration.
###end p 43
###begin title 44
Methods
###end title 44
###begin title 45
Induction of EAE
###end title 45
###begin p 46
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 43 47 43 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 345 349 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 349 353 349 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 471 476 469 474 <sub xmlns:xlink="http://www.w3.org/1999/xlink">35&#8211;55</sub>
###xml 1041 1043 1039 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 1116 1119 1114 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 1123 1127 1121 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 1127 1131 1125 1129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 102 106 <span type="species:ncbi:10090">Mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 421 424 <span type="species:ncbi:31658">CFA</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
###xml 760 764 <span type="species:ncbi:10090">mice</span>
The generation and characterization of mmp7-/- mice on the C57BL/6 background has been reported [59]. Mice that had been back-crossed for at least 10 generations, onto the C57Bl/6 background, were bred in the University of California, Riverside (UCR) vivarium in accordance with Institutional and NIH animal care and use guidelines. Age-matched mmp7-/- and wt (B6) mice were injected at 7-18 weeks of age with 100 mul of CFA emulsion containing 250 mug of recombinant MOG35-55, divided into three sites on shaved backs. Recombinant MOG was synthesized at the University of California Los Angeles (UCLA) peptide core and was 97-99% pure. One and 3 days after MOG injections, mice were given intra-peritoneal injections of 200 ng pertussis toxin each. Each day, mice were scored for clinical signs of EAE as follows: 0 = no EAE; 1 = total loss of tail tonicity; 2 = hind limb weakness, impaired righting reflex, or forelimb impairment alone; 3 = total paralysis of one or both hind limbs; 4 = hind and forelimb paralysis; 5 = moribund, death [60]. Statistical analysis was done by paired Student-t Tests (2-tailed) of wt and mmp7-/- clinical scores at each time-point.
###end p 46
###begin title 47
Splenocyte and Lymphocyte Isolation
###end title 47
###begin p 48
###xml 811 813 807 809 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Spleen and draining lymph nodes were isolated from experimental and control mice 15-24 days after post MOG injection. Tissues were disrupted in complete RPMI with 5-7 strokes of a glass Dounce (15 mL Pyrex). Single-cell suspensions were prepared by passing homogenates over a 70-mum sieve filter (BD, Franklin Lakes, NJ) and rinsing with 2 mL of complete RPMI. Cells were pelleted and red blood cells lysed by resuspension in cold buffer (Red blood cell lysis buffer, Sigma, St. Louis, MO) for 5 min on ice. Next, cells were pelleted and resuspended in RPMI 1640 media containing 10% FCS (Hyclone, Logan, UT), L-glutamine, sodium bicarbonate, sodium pyruvate, essential and non-essential amino acids, vitamins, penicillin/streptomycin, and beta-mercaptoethanol (complete RPMI), and maintained in a humidified CO2 incubator at 37degreesC. Viable cells were counted by trypan blue exclusion.
###end p 48
###begin title 49
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
3H-Thymidine Measurement of Proliferation
###end title 49
###begin p 50
###xml 27 30 27 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 40 44 40 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 161 163 161 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 252 258 251 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink">35&#8211;55 </sub>
###xml 326 327 318 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 797 801 <span type="species:ncbi:10090">mice</span>
Cells were isolated from 3 wt and 3 mmp7-/- mice 15 days after vaccination with MOG, as described. Quadruplicate wells of each condition consisted of 2 or 4 x 105 cells/well in a 96-well plate, and cultured in the presence of 0, 10, 20 or 30 mug/mL MOG35-55 overnight at 37degreesC. Cells were then pulsed with 1 muCi/well of 3H-thymidine (ICN Pharmaceuticals, Costa Mesa, CA) for the last 4 h of culture, and processed using a cell harvester (PHD, Cambridge Technologies). Each sample was cut from the filter and radioactivity measured with a scintillation counter. Mean values from quadruplicates were used to generate proliferation responses that were normalized to the control condition (0 mug/mL MOG) for cells from each animal. These normalized proliferation responses were averaged for all mice of each genotype.
###end p 50
###begin title 51
CFSE Labelling and Analysis
###end title 51
###begin p 52
###xml 105 107 105 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 596 598 589 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 887 889 872 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 1042 1046 1021 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
Freshly isolated splenocytes and lymphocytes were pooled, pelleted, and then resuspended in PBS at 6 x 107 cells/ml. An equal volume of PBS containing 10 muM carboxy-fluorescein diacetate succinimidyl ester (CFSE; Molecular Probes, Inc. Eugene, OR) was added, then cells were gently mixed and incubated for 20 min at 37degreesC. Cells were pelleted and washed twice with PBS. Immediate FACS analysis of an aliquot determined cell labelling efficiency, typically >99%, and those values were used as baseline labelling of the parental generation. CFSE-labelled cells were then resuspended (2.5 x 106 cells/ml) in complete RPMI with 0, 10, or 15 muM MOG, or 25 units/ml IL-2 and incubated at 37degreesC for 4 days. Aliquots of each preparation were then labelled with fluorescently-conjugated (PE) anti-CD4, anti-CD8, or isotype-specific controls (BD Biosciences, San Diego, CA) at 1 mug/106 cells, 25 min at 4degreesC. Cells were then rinsed with PBS (3x) and fixed with an equal volume of 2% paraformaldehyde. Data was acquired using a FACScan(R) (Becton Dickinson, San Jose, CA), and analyzed using ModFittrade mark software proliferation wizard (Becton Dickinson, San Jose, CA). Typically, 15-50,000 events were collected for each sample.
###end p 52
###begin title 53
Adoptive Transfer
###end title 53
###begin p 54
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 70 74 70 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 164 166 163 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 219 221 218 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
Primary splenocytes and lymphocytes were isolated from MOG-primed mmp7-/- mice 10 days after vaccination and cultured with 10 mug/ml MOG and 10 ng/ml IL-2 (2.5 x 106 cells/ml) for 5 days. Recipient mice received 20 x 106 cells in 0.2 mL of PBS by tail-vein injection.
###end p 54
###begin title 55
Immunostaining
###end title 55
###begin p 56
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
###xml 619 623 <span type="species:ncbi:9925">goat</span>
###xml 740 745 <span type="species:ncbi:10090">mouse</span>
###xml 785 791 <span type="species:ncbi:9986">rabbit</span>
###xml 831 836 <span type="species:ncbi:10090">mouse</span>
###xml 874 879 <span type="species:ncbi:10090">mouse</span>
###xml 910 915 <span type="species:ncbi:10090">mouse</span>
###xml 944 949 <span type="species:ncbi:10090">mouse</span>
###xml 1040 1046 <span type="species:ncbi:9986">rabbit</span>
###xml 1090 1093 <span type="species:ncbi:10116">rat</span>
###xml 1151 1156 <span type="species:ncbi:10090">mouse</span>
Immediately following the removal of spleen and lymph nodes each mouse was perfused (cardiac) with saline containing heparin, saline alone, and then fresh 4% paraformaldehyde in PBS. The isolated cranium and spinal column were post-fixed overnight in paraformaldehyde, after which the brain and spinal cord were carefully removed. Tissue was cryo-protected with increasing sucrose concentrations and then sectioned on a cryostat (7 mum), and stored at 4degreesC until use. Slide-mounted sections were warmed to 37degreesC for 10 min, rinsed with PBS, and non-specific antigens blocked with either 10% BSA or 10% normal goat serum (NGS) for 1 h, depending on the sources and specificities of the antibodies to be used. Antibodies used were: mouse anti-MMP-7 (1:100; Dr. Carole Wilson), rabbit anti-MMP-7 (1:100; Dr. Carole Wilson), mouse anti-CD4-PE (1:100; BD Biosciences), mouse anti-GFAP-PE (1:2000; Sigma), mouse anti-Gr-1 (BD Biosciences), mouse Iba-1-FITC (1:100; Genetex, #1022-5). Secondary antibodies used were FITC-conjugated anti-rabbit IgG (1:100; Sigma) and Cy3-conjugated anti-rat IgG (1:100; Molecular Probes); Alexa-488 conjugated anti-mouse (1:1000; Invitrogen).
###end p 56
###begin title 57
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
In vitro BBB Model
###end title 57
###begin p 58
###xml 57 59 57 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 791 794 791 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink">st </sup>
###xml 873 876 873 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink">nd </sup>
###xml 82 85 <span type="species:ncbi:10116">rat</span>
###xml 289 292 <span type="species:ncbi:10116">rat</span>
###xml 658 663 <span type="species:ncbi:9606">human</span>
The system used has been described in detail previously [61,62]. Briefly, primary rat-brain micro-vascular endothelial cells were cultured on the lumen surface of porous tubes, and grown with constant perfusion of media through the lumen of the tubes. Outside the tubes were grown primary rat astrocytes, which supplied signalling molecules necessary to create tight junctions between endothelial cells sufficient to be recorded as resistance. Experiments were done at week 3 of EC-astrocyte co-culture in this dynamic in vitro BBB model when all tubes were measured for resistance and only those showing significant resistance were used. Active recombinant human MMP-7 (Millipore, Temecula, CA) was added to the extra capillary space (astrocyte) side of the system at 1 or 5 units per mL (1st group of experiments), or to the lumenal (endothelial) side at 1 unit per mL (2nd group of experiments). In both experimental series MMP-7 was added with continuous perfusion in one set of experiments, or with a 1.5 h pause of flow followed by reperfusion in separate experiments. Permeability of the endothelial sheets was measured by standard electrophysiological recording as the trans-endothelial electrical resistance (TEER) between the ECS and lumen.
###end p 58
###begin title 59
Abbreviations
###end title 59
###begin p 60
###xml 382 386 382 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 386 389 386 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 613 615 613 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt</italic>
###xml 486 490 <span type="species:ncbi:9925">goat</span>
BBB: blood-brain barrier; BCB: blood-CSF-barrier; CFSE: carboxy-fluorescein diacetate succinimidyl ester; CNS: central nervous system; CSF: cerebrospinal fluid; EAE: experimental autoimmune encephalomyelitis; ECM: extracellular matrix; FasL: Fas ligand; GFAP: glial fibrillary acidic protein; GM-CSF: granulocyte macrophage colony stimulating factor; MMP: matrix metalloproteinase; mmp7-/-: MMP-7 deficient; MOG: myelin oligodendrocyte glycoprotein; MS: multiple sclerosis; NGS: normal goat serum; sFasL: soluble Fas ligand; TEER: trans-endothelial electrical resistance; UCR: University of California Riverside; wt: wild-type.
###end p 60
###begin title 61
Authors' contributions
###end title 61
###begin p 62
###xml 214 218 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 218 222 218 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
LAB and RS performed adoptive transfers and evaluated clinical scores. DWE designed and supervised the study, performed immunostaining, and wrote the manuscript. EG assisted with immunological assays. CLW provided mmp7-/- mice and MMP-7 specific antibodies. LK-B and DJ performed in vitro BBB assays. All authors read and approved the final manuscript.
###end p 62
###begin title 63
Supplementary Material
###end title 63
###begin title 64
Additional file 1
###end title 64
###begin p 65
###xml 110 113 110 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 0 131 0 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Movie from a confocal image stack showing MMP-7 immunopositive cells in a perivascular cuff from a MOG-primed <italic>wt </italic>mouse, during EAE.</bold>
###xml 113 118 <span type="species:ncbi:10090">mouse</span>
###xml 136 141 <span type="species:ncbi:10090">mouse</span>
Movie from a confocal image stack showing MMP-7 immunopositive cells in a perivascular cuff from a MOG-primed wt mouse, during EAE. The mouse had been vaccinated with MOG 15 days prior and demonstrated a clinical score of 1 at the time of sacrifice.
###end p 65
###begin p 66
Click here for file
###end p 66
###begin title 67
Additional file 2
###end title 67
###begin p 68
###xml 0 79 0 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Confocal microscopy shows co-localization of MMP-7 with tomato lectin and Gr-1.</bold>
###xml 173 176 173 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 56 62 <span type="species:ncbi:4081">tomato</span>
###xml 102 108 <span type="species:ncbi:4081">tomato</span>
###xml 176 181 <span type="species:ncbi:10090">mouse</span>
###xml 399 405 <span type="species:ncbi:4081">tomato</span>
###xml 547 552 <span type="species:ncbi:10090">mouse</span>
Confocal microscopy shows co-localization of MMP-7 with tomato lectin and Gr-1. (a) Confocal image of tomato lectin-stained cells (red) in a vascular cuff in the brain of a wt mouse during EAE, 15 days after vaccination with a clinical score of 1. (b) Confocal image of the same section in a showing MMP-7 immunostaining (green). (c) Merged image of boxes a and b shows co-localization of MMP-7 and tomato lectin in a perivascular accumulation of immune cells during EAE. (d) Confocal image of Gr-1 immunopositive cells (red) in the brain of a WT mouse during EAE. (e) Confocal image of the same section in d showing MMP-7 immunopositive cells (green). (f) Merged image of d and e shows co-localization of MMP-7 and Gr-1.
###end p 68
###begin p 69
Click here for file
###end p 69
###begin title 70
Additional file 3
###end title 70
###begin p 71
###xml 80 83 80 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 91 95 91 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 101 0 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Proliferation responses of splenocytes and lymphocytes isolated from MOG-primed <italic>wt </italic>and <italic>mmp7</italic><sup>-/- </sup>mice. </bold>
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 179 183 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 183 187 183 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 268 269 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 487 491 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp7</italic>
###xml 491 495 489 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 580 583 578 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt </italic>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 324 328 <span type="species:ncbi:10090">mice</span>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
###xml 583 587 <span type="species:ncbi:10090">mice</span>
Proliferation responses of splenocytes and lymphocytes isolated from MOG-primed wt and mmp7-/- mice. (a) 3H-Thymidine incorporation of splenocytes isolated from MOG-primed wt and mmp7-/- mice and re-stimulated for 4 days in vitro with 0, 10, 20, or 30 mug/ml MOG. (b) 3H-Thymidine incorporation of lymphocytes from the same mice and re-stimulated for 4 days in vitro with 0, 10, 20 or 30 mug/ml MOG. Although proliferation tended to be lower in splenocytes and lymphocytes isolated from mmp7-/- mice, the differences were not statistically significant in comparison to cells from wt mice.
###end p 71
###begin p 72
Click here for file
###end p 72
###begin title 73
Acknowledgements
###end title 73
###begin p 74
We thank Dan Welch and Xiaoqiao Xie for technical assistance, Dr. Laurie Owen for discussions and Dr. William Parks for critical comments. This work was supported by grants from the National Multiple Sclerosis Society (PP0842) and the National Institutes of Health (AG21652) to DE.
###end p 74
###begin article-title 75
The blood-brain barrier and its role in immune privilege in the central nervous system
###end article-title 75
###begin article-title 76
Reversal of experimental autoimmune encephalomyelitis with hydroxamate inhibitor of matrix metalloproteases
###end article-title 76
###begin article-title 77
###xml 68 71 <span type="species:ncbi:10116">rat</span>
Suppression of experimental allergic encephalomyelitis in the Lewis rat by matrix metalloproteinase inhibitor Ro31-9790
###end article-title 77
###begin article-title 78
Matrix metalloproteinase expression during experimental allergic encephalomyelitis and effects of a combined metalloproteinase and tumor necrosis factor-alpha inhibitor
###end article-title 78
###begin article-title 79
Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors
###end article-title 79
###begin article-title 80
Pilot study of minocycline in relapsing-remitting multiple sclerosis
###end article-title 80
###begin article-title 81
###xml 40 45 <span type="species:ncbi:9606">human</span>
Matrix metalloproteinases in the normal human central nervous system, microglial nodules and multiple sclerosis lesions
###end article-title 81
###begin article-title 82
The expression of tissue type plasminogen activator, matrix metalloproteinases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution
###end article-title 82
###begin article-title 83
Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke
###end article-title 83
###begin article-title 84
Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions
###end article-title 84
###begin article-title 85
###xml 104 107 <span type="species:ncbi:10116">rat</span>
Matrix metalloproteinase expression in an experimentally-induced DTH model of Multiple sclerosis in the rat CNS
###end article-title 85
###begin article-title 86
Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis
###end article-title 86
###begin article-title 87
Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis
###end article-title 87
###begin article-title 88
###xml 90 98 <span type="species:ncbi:9606">patients</span>
Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis
###end article-title 88
###begin article-title 89
Metalloproteinaese and their tissue inhibitors in multiple sclerosis
###end article-title 89
###begin article-title 90
The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis
###end article-title 90
###begin article-title 91
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis
###end article-title 91
###begin article-title 92
Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators
###end article-title 92
###begin article-title 93
###xml 31 35 <span type="species:ncbi:10090">mice</span>
Resistance of young gelatinase mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions
###end article-title 93
###begin article-title 94
Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an inorganic molecule inhibits angiogenesis and tumor growth in vivo
###end article-title 94
###begin article-title 95
Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by MMP-7
###end article-title 95
###begin article-title 96
###xml 103 108 <span type="species:ncbi:9606">human</span>
Decreased synthesis of matrix metalloproteinase-7 and adhesion to the extracellular matrix proteins of human colon cancer cells treated with troglitazone
###end article-title 96
###begin article-title 97
Cleavage of beta 4 integrin by matrilysin
###end article-title 97
###begin article-title 98
###xml 103 108 <span type="species:ncbi:9606">human</span>
Matrilysin (MMP-7) degrades VE-cadherin and accelerates accumulation of beta-catenin in the nucleus of human umbilical vein endothelial cells
###end article-title 98
###begin article-title 99
Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1
###end article-title 99
###begin article-title 100
Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion
###end article-title 100
###begin article-title 101
Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium
###end article-title 101
###begin article-title 102
###xml 82 88 <span type="species:ncbi:10090">murine</span>
###xml 93 98 <span type="species:ncbi:9606">human</span>
Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand
###end article-title 102
###begin article-title 103
Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neurtophils in acute lung injury
###end article-title 103
###begin article-title 104
Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes
###end article-title 104
###begin article-title 105
Gelatinase-B: structure, regulation, and function
###end article-title 105
###begin article-title 106
Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8(+) T cells produce active immune unresponsiveness
###end article-title 106
###begin article-title 107
CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons
###end article-title 107
###begin article-title 108
Presence and significance of CD-95 (Fas/APO1) expression after spinal cord injury
###end article-title 108
###begin article-title 109
Fas receptor and neuronal cell death after spinal cord ischemia
###end article-title 109
###begin article-title 110
Neuronal FasL induces cell death of encephalitogenic T lymphocytes
###end article-title 110
###begin article-title 111
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand
###end article-title 111
###begin article-title 112
Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity
###end article-title 112
###begin article-title 113
###xml 26 31 <span type="species:ncbi:9606">human</span>
Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing
###end article-title 113
###begin article-title 114
Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas
###end article-title 114
###begin article-title 115
Chemotactic activity of soluble Fas ligand against phagocytes
###end article-title 115
###begin article-title 116
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice
###end article-title 116
###begin article-title 117
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Induction of autoimmune encephalomyelitis and uveitis in B6 and (B6 x SJL) mice by peptides derived from myelin/oligodendrocyte glycoprotein
###end article-title 117
###begin article-title 118
Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7)
###end article-title 118
###begin article-title 119
Heparan sulfate proteoglycans modulate monocyte migration across cerebral endothelium
###end article-title 119
###begin article-title 120
Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption
###end article-title 120
###begin article-title 121
###xml 36 41 <span type="species:ncbi:9606">human</span>
Matrilysin-dependent elastolysis by human macrophages
###end article-title 121
###begin article-title 122
Microarray analysis of activated mixed glial (migroglia) and monocyte-derived macrophage gene expression
###end article-title 122
###begin article-title 123
A new dynamic in vitro model for the multidimensional study of astrocyte-endothelial cell interactions at the blood-brain barrier
###end article-title 123
###begin article-title 124
Fas ligand-mediated apoptosis in degenerative disorders of the brain
###end article-title 124
###begin article-title 125
Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis
###end article-title 125
###begin article-title 126
Granulocyte macrophage colony-stimulating factor: A new putative therapeutic target in multiple sclerosis
###end article-title 126
###begin article-title 127
MMP-7 disrupts spines in hippocampal neurons through NMDA receptor activation
###end article-title 127
###begin article-title 128
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
Minocycline promotes dendritic spine maturation and improves behavioral performance in the Fragile x mouse model
###end article-title 128
###begin article-title 129
Ephrin-B2 induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsion
###end article-title 129
###begin article-title 130
TNFR1 signalling is critical for the development of demyelination and the limitation of T cell responses during immune-mediated CNS disease
###end article-title 130
###begin article-title 131
###xml 182 190 <span type="species:ncbi:9606">patients</span>
Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients
###end article-title 131
###begin article-title 132
Matrix Metalloproteinases in brain development and remodeling: Synaptic functions and targets
###end article-title 132
###begin article-title 133
Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense
###end article-title 133
###begin article-title 134
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Oligodendrocyte-specific protein peptides induce experimental autoimmune encephalomyelitis in SJL/J mice
###end article-title 134
###begin article-title 135
###xml 49 52 <span type="species:ncbi:10116">rat</span>
Use of a three-dimensional in vitro model of the rat blood-brain barrier to assay nucleoside efflux from brain
###end article-title 135
###begin article-title 136
Effects of transient loss of shear stress on blood-brain barrier endothelium: role of nitric oxide and IL-6
###end article-title 136

